Paid Clinical Trials Michigan
Discover 1,439 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Aromatase InhibitorAromatase Inhibitor Clinical Trial
Sponsor:
National Institute of General Medical Sciences (NIGMS)
Location:
Code:
NCT00228956
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 40 - 70
Healthy Volunteers: Not accepted
Interventions
pharmacodynamic analysis
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMTDevelopment of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Sponsor:
University of Iowa
Location:
Code:
NCT01203085
Conditions
Charcot Marie Tooth Disease
Eligibility Criteria
Sex: All
Age: 0 - 21
Healthy Volunteers: Not accepted
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
AI-081Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Sponsor:
OncoC4, Inc.
Location:
Code:
NCT06635785
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AI-081
RRMMMMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Sponsor:
Multiple Myeloma Research Consortium
Location:
Code:
NCT06171685
Conditions
Relapse Multiple Myeloma
Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Teclistamab Monotherapy
Teclistamab
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
Avapritinib with DecitabineAvapritinib With Decitabine in Patients With SM-AHN
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Location:
Code:
NCT06327685
Conditions
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Avapritinib
Decitabine
Decitabine/Cedazuridine
BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Sponsor:
Blueprint Medicines Corporation
Location:
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo
Selinexor & ChemotherapySelinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
Sponsor:
Barbara Ann Karmanos Cancer Institute
Location:
Code:
NCT03147885
Conditions
Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma
Recurrent Extranodal Marginal Zone Lymphoma
Recurrent Follicular Lymphoma
Recurrent Indolent Adult Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor